16-1202219-G-A
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_021098.3(CACNA1H):c.1769G>A(p.Arg590Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000727 in 1,554,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R590W) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 missense
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | NM_021098.3 | MANE Select | c.1769G>A | p.Arg590Gln | missense | Exon 9 of 35 | NP_066921.2 | ||
| CACNA1H | NM_001005407.2 | c.1769G>A | p.Arg590Gln | missense | Exon 9 of 34 | NP_001005407.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | TSL:1 MANE Select | c.1769G>A | p.Arg590Gln | missense | Exon 9 of 35 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6 | TSL:1 | c.1769G>A | p.Arg590Gln | missense | Exon 9 of 34 | ENSP00000454990.2 | ||
| CACNA1H | ENST00000711493.1 | c.1769G>A | p.Arg590Gln | missense | Exon 9 of 34 | ENSP00000518778.1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152252Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000924 AC: 14AN: 151460 AF XY: 0.0000973 show subpopulations
GnomAD4 exome AF: 0.0000720 AC: 101AN: 1402186Hom.: 0 Cov.: 36 AF XY: 0.0000693 AC XY: 48AN XY: 692318 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152252Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74398 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at